Nuvation Bio Inc.
NUVB · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Hattersley Gary: Form 4
Insider disclosure · Filed · Report period 19 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- NUVB · 67080N101 - Common Stock
Company details and SEC sources
CIK 0001811063 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NUVB on NYSE
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1500 Broadway, Suite 1401, New York, NY, 10036
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Panacea Acquisition Corp (to 11 Feb 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields